WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H563113
CAS#: 1421931-13-6
Description: SW116 is a fluorescent sigma-2 selective ligand.
Hodoodo Cat#: H563113
Name: SW116
CAS#: 1421931-13-6
Chemical Formula: C39H56N4O6S
Exact Mass: 708.39
Molecular Weight: 708.950
Elemental Analysis: C, 66.07; H, 7.96; N, 7.90; O, 13.54; S, 4.52
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: SW116; SW-116; SW 116;
IUPAC/Chemical Name: (2,5-Dimethoxy-phenyl)-carbamic acid 9-[10-(5-dimethylamino-naphthalene-1-sulfonylamino)-decyl]-9-aza-bicyclo[3.3.1]non-3-yl ester
InChi Key: RMGKFZJINTURGE-UHFFFAOYSA-N
InChi Code: InChI=1S/C39H56N4O6S/c1-42(2)36-20-14-19-34-33(36)18-15-21-38(34)50(45,46)40-24-11-9-7-5-6-8-10-12-25-43-29-16-13-17-30(43)27-32(26-29)49-39(44)41-35-28-31(47-3)22-23-37(35)48-4/h14-15,18-23,28-30,32,40H,5-13,16-17,24-27H2,1-4H3,(H,41,44)
SMILES Code: O=C(OC1CC(N2CCCCCCCCCCNS(=O)(C3=C4C=CC=C(N(C)C)C4=CC=C3)=O)CCCC2C1)NC5=CC(OC)=CC=C5OC
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 708.95 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Deng C, Xiong J, Gu X, Chen X, Wu S, Wang Z, Wang D, Tu J, Xie J. Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro. Oncotarget. 2017 Jun 13;8(24):38568-38580. doi: 10.18632/oncotarget.16930. PubMed PMID: 28445134; PubMed Central PMCID: PMC5503554.
2: Sun J, Ren SZ, Lu XY, Li JJ, Shen FQ, Xu C, Zhu HL. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Bioorg Med Chem. 2017 May 1;25(9):2593-2600. doi: 10.1016/j.bmc.2017.03.038. Epub 2017 Mar 19. PubMed PMID: 28363444.
3: Sørensen BS, Knudsen A, Wittrup CF, Nielsen S, Aggerholm-Pedersen N, Busk M, Horsman M, Høyer M, Bouchelouche PN, Overgaard J, Alsner J. The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types. Radiother Oncol. 2015 Sep;116(3):346-51. doi: 10.1016/j.radonc.2015.06.028. Epub 2015 Jul 10. PubMed PMID: 26169282.
4: Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD, Ran ZH. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. PLoS One. 2012;7(8):e41763. doi: 10.1371/journal.pone.0041763. Epub 2012 Aug 1. PubMed PMID: 22870247; PubMed Central PMCID: PMC3411563.
5: Zhou HM, Dong TT, Wang LL, Feng B, Zhao HC, Fan XK, Zheng MH. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. World J Gastroenterol. 2012 Jun 7;18(21):2640-8. doi: 10.3748/wjg.v18.i21.2640. PubMed PMID: 22690072; PubMed Central PMCID: PMC3370000.
6: Shi F, Tao ZL, Luo SW, Tu SJ, Gong LZ. Scaffold-inspired enantioselective synthesis of biologically important spiro[pyrrolidin-3,2'-oxindoles] with structural diversity through catalytic isatin-derived 1,3-dipolar cycloadditions. Chemistry. 2012 May 29;18(22):6885-94. doi: 10.1002/chem.201200358. Epub 2012 Apr 13. PubMed PMID: 22505189.
7: Jiang H, Tang Y, Garg HK, Parthasarathy DK, Torregrossa AC, Hord NG, Bryan NS. Concentration- and stage-specific effects of nitrite on colon cancer cell lines. Nitric Oxide. 2012 May 15;26(4):267-73. doi: 10.1016/j.niox.2012.03.010. Epub 2012 Apr 5. PubMed PMID: 22504070.
8: Zeng C, Vangveravong S, Jones LA, Hyrc K, Chang KC, Xu J, Rothfuss JM, Goldberg MP, Hotchkiss RS, Mach RH. Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. Mol Imaging. 2011 Dec;10(6):420-33. PubMed PMID: 22201533; PubMed Central PMCID: PMC4426860.
9: Wu JY, Xu XF, Xu L, Niu PQ, Wang F, Hu GY, Wang XP, Guo CY. Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1511-8. doi: 10.5754/hge10765. Epub 2011 Jul 15. PubMed PMID: 21940310.
10: Chopra A. Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles . 2008 Nov 20 [updated 2008 Dec 17]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK23104/ PubMed PMID: 20641309.
11: Wang HT, Zhang Z, Fan M, Wang L, Dong GL. [Expression of CD112 in colon carcinoma tissues and cell lines and their clinical significance]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 May;26(5):477-9. Chinese. PubMed PMID: 20617580.
12: Hochwald SN, Lind DS, Malaty J, Copeland EM 3rd, Moldawer LL, MacKay SL. Antineoplastic therapy in colorectal cancer through proteasome inhibition. Am Surg. 2003 Jan;69(1):15-23. PubMed PMID: 12575774.
13: Maas IW, Boven E, Pinedo HM, Schlüper HM, Haisma HJ. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines. Int J Cancer. 1991 Jul 9;48(5):749-56. PubMed PMID: 1830034.
